The clinical significance of sialoderiveratives in the search for novel means of antipathogen therapy

Equine Veterinary Journal

Volumn 38, Issue 5, 2006, Pages 390-392

  Werling, D ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947310422     PISSN: 14336863     EISSN: 04251644     Source Type: Book Series    
DOI: 10.2746/042516406778400600     Document Type: Short Survey

References (8)

1. Beigel, J.H., Farrar, J., Han, A.M., Hayden, F.G., Hyer, R., de Jong, M.D., Lochindarat, S., Nguyen, T.K., Nguyen, T.H., Tran, T.H., Nicoll, A., Touch, S. and Yuen, K.Y. (2005) Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353, 1374-1385.
2. Blix, F.G., Gottschalk, A. and Klenk, E. (1957) Proposed nomenclature in the field of neuraminic and sialic acids. Nature 179, 1088.
3. Ryan, D.M., Ticehurst, J. and Dempsey, M.H. (1995) GG167 (4-guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob. Agents. Chemother. 39, 2583-2584.
4. Scocco, P. and Pedini, V. (2006) Horse mandibular gland: in situ characterisation of sialoderivatives. Equine vet. J. 38, 410-415.
5. Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N. and Kawaoka, Y. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440, 435-436.
6. Smith, B.J., Colman, P.M., Von Itzstein, M., Danylec, B. and Varghese, J.N. (2001) Analysis of inhibitor binding in influenza virus neuraminidase. Protein Sci. 10, 689-696.
7. Stevens, J., Blixt, O., Tumpey, T.M., Taubenberger, J.K., Paulson, J.C. and Wilson, I.A. (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404-410.
8. Suzuki, Y. (2005) Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 28, 399-408.